ロード中...
Comparative Efficacy of Olmesartan, Losartan, Valsartan, and Irbesartan in the Control of Essential Hypertension
In a multicenter, randomized, double‐blind trial, the authors compared the antihypertensive efficacy of once‐daily treatment with the new angiotensin II type 1 receptor blocker (ARB) olmesartan (20 mg) with recommended starting doses of losartan (50 mg), valsartan (80 mg), and irbesartan (150 mg) in...
保存先:
| 出版年: | J Clin Hypertens (Greenwich) |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Le Jacq Communications, Inc.
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8101821/ https://ncbi.nlm.nih.gov/pubmed/11588406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2001.01136.x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|